Hit cancer early or wait? major trial tests timing of radiation for spread tumors
NCT ID NCT06563388
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This phase 3 trial tests whether treating 1 to 10 metastatic tumors right away with precise radiation improves survival compared to waiting 3 months. It includes 800 adults with lung, colorectal, or prostate cancer that has spread to a few spots. Participants are randomly assigned to get radiation immediately or after a delay, while both groups receive standard care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Stereotactic ablative radiotherapy (SABR/SBRT)
- What this could lead to
- If immediate treatment improves survival or delays the need for hormone therapy, this could change standard care for patients with a few metastatic tumors.
- What could go wrong
- This is a single-center trial, and results may not apply to all patients. Delayed treatment might not worsen outcomes, and quality-of-life differences could be small.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLO-RECTAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Roswell Park Comprehensive Cancer Center
RECRUITINGBuffalo, New York, 14263, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new tracer light up hidden prostate cancer?
- Can a simple CT scan catch lung cancer earlier in kuwait?
- Could deep breaths before surgery ward off Post-Op confusion?
- Can a new drug combo revive Immunotherapy's power against resistant tumors?
- A second look: MRI screening may spot hidden prostate cancers
- Seeing the fight: new imaging tracer may reveal how immune cells attack lung cancer